RBx-7796

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRBx-7796
Drug Alias NameRBx-7796
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonistsArachidonate 5-lipoxygenase inhibitors
TargetsIntegrin alpha-4/beta-1Arachidonate 5-lipoxygenase
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesSun Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSun Pharmaceutical Industries Ltd
Inactive CompaniesN/A
Active IndicationsRhinitis, AllergicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A